Coenzyme A metabolism in fungi: a new frontier in antifungal therapy

Area of Science:

• Medical Microbiology
• Biochemistry
• Drug Discovery

Background:

• Fungal infections cause significant global mortality, with limited treatment options and rising drug resistance.
• Invasive fungal infections pose a severe threat, necessitating novel therapeutic strategies.
• Existing antifungal drugs have limitations, especially against multidrug-resistant strains.

Purpose of the Study:

• To review the fungal coenzyme A (CoA) biosynthesis pathway as a therapeutic target.
• To highlight recent advances in discovering compounds targeting CoA biosynthesis.
• To explore the potential of CoA pathway inhibitors in combating fungal infections and resistance.

Main Methods:

• Literature review of fungal CoA biosynthesis.
• Analysis of novel compounds targeting the CoA pathway.
• Evaluation of compound efficacy as standalone inhibitors and potentiators of existing antifungals.

Main Results:

• The fungal CoA biosynthesis pathway is essential for fungal physiology with distinct differences from humans.
• Novel compounds targeting CoA metabolism show promise as standalone antifungal agents.
• These compounds can potentiate existing antifungals, enhancing susceptibility and overcoming resistance mechanisms.

Conclusions:

• Coenzyme A (CoA) metabolism represents a viable and promising target for next-generation antifungal therapies.
• Targeting CoA biosynthesis offers a multifaceted approach to address limitations of current antifungal treatments.
• Developing CoA pathway inhibitors can significantly reduce mortality associated with invasive fungal infections.